Overview

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine when HIV infected children should begin taking anti-HIV medications in order to improve both patient quality of life and survival.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Comprehensive International Program of Research on AIDS
Treatments:
Abacavir
Efavirenz
Lamivudine
Lopinavir
Nelfinavir
Nevirapine
Ritonavir
Zidovudine